| C03CA01 |
Furosemide |
C03CA01 Furosemide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C03CA01 |
Furosemide |
Furantril |
Tablet |
40 |
mg |
12 |
Актавис EАД, България |
40 |
mg |
- |
1.73 |
0.0565 |
0.68 |
50% |
0.34 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
НСР-6386/03.06.2015.; КП-76/05.10.2018 и НСР-16486/17.08.2018; НСР-20609/16.01.2020 |
02.02.2020 |
|
|
Активен |
91 |
| C03CA01 |
Furosemide |
Furantril |
Tablet |
40 |
mg |
12 |
Актавис EАД, България |
40 |
mg |
- |
1.44 |
0.04667 |
0.56 |
50% |
0.28 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,N18.0,N18.8 |
НСР-6385/03.06.2015 |
02.07.2015 |
|
|
Заличен |
91 |
| C03CA01 |
Furosemide |
Furosemide Sopharma |
Tablet |
40 |
mg |
20 |
Софарма АД, България |
40 |
mg |
- |
1.13 |
0.0565 |
1.13 |
50% |
0.56 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
НСР-6575/29.06.2015. |
02.07.2015 |
|
|
Активен |
4027 |
| C03CA01 |
Furosemide 100% |
C03CA01 Furosemide 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C03CA01 |
Furosemide |
Furantril |
Tablet |
40 |
mg |
12 |
Актавис EАД, България |
40 |
mg |
1.45 |
- |
0.0475 |
0.57 |
100% |
0.57 |
|
I10 |
HCP-8733/13.04.2016.; КП-76/05.10.2018 и НСР-16486/17.08.2018.; НСР-20609/16.01.2020 |
02.02.2020 |
|
|
Активен |
91 |
| C03CA01 |
Furosemide |
Furosemide Sopharma |
Tablet |
40 |
mg |
20 |
Софарма АД, България |
40 |
mg |
0.95 |
- |
0.0475 |
0.95 |
100% |
0.95 |
|
I10 |
HCP-8734/13.04.2016. |
02.08.2019 |
|
|
Активен |
4027 |
| C03CA04 |
Torasemide |
C03CA04 Torasemide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C03CA04 |
Torasemide |
TORAZIDEX |
Tablet |
5 |
mg |
30 |
Sandoz d.d., Словения |
15 |
mg |
- |
6.73 |
0.505 |
5.05 |
50% |
2.53 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
№ 162/ 20.04.2011; НСР-817/07.08.2013; НСР-3283/24.04.2014; НСР-8366/26.02.2016; НСР-13345/28.07.2017; НСР-15798/08.06.2018 |
02.07.2018 |
08.09.2012 |
|
Активен |
2728 |
| C03CA04 |
Torasemide |
TORAZIDEX |
Tablet |
10 |
mg |
30 |
Sandoz d.d., Словения |
15 |
mg |
- |
11.63 |
0.505 |
10.1 |
50% |
5.05 |
|
I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
№ 162/ 20.04.2011; НСР-15798/08.06.2018 |
02.07.2018 |
08.09.2012 |
|
Активен |
997 |
| C03CA04 |
Torasemide |
Torsit SR |
Prolonged release tablet |
10 |
mg |
30 |
Ferrer International S.A.,, Испания |
15 |
mg |
- |
10.1 |
0.505 |
10.1 |
50% |
5.05 |
|
I11.0,I12.0,I13.0,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
КЦРР-1662/20.11.2012 г. НСР-899/09.08.2013; НСР-2964/07.03.2014; НСР-19358/26.07.2019 |
02.09.2019 |
|
|
Активен |
2096 |
| C03CA04 |
Torasemide |
Torsit SR |
Prolonged release tablet |
5 |
mg |
30 |
Ferrer International S.A.,, Испания |
15 |
mg |
- |
5.05 |
0.505 |
5.05 |
50% |
2.53 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
КЦРР-1662/20.11.2012 г.; НСР-898/09.08.2013; НСР-2964/07.03.2014; НСР-4930/22.10.2014; HCP-10138/31.08.2016; НСР-19357/26.07.2019 |
02.09.2019 |
|
|
Активен |
3317 |
| C03CA04 |
Torasemide |
TRIFAS |
Tablet |
10 |
mg |
30 |
Menarini International Operations Luxembourg S.A., Люксембург |
15 |
mg |
- |
13.09 |
0.505 |
10.1 |
50% |
5.05 |
|
I50.0,I50.1 |
№ 66/ 08.04.2010; № 77/ 22.04.2010; № 85/17.06.2010 |
02.10.2013 |
08.09.2012 |
|
Активен |
537 |
| C03CA04 |
Torasemide |
TRIFAS COR |
Tablet |
5 |
mg |
30 |
Menarini International Operations Luxembourg S.A., Люксембург |
15 |
mg |
- |
8.74 |
0.505 |
5.05 |
50% |
2.53 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1 |
№ 66/ 08.04.2010; № 77/ 22.04.2010; № 85/17.06.2010; НСР-19789/10.09.2019 |
02.10.2019 |
08.09.2012 |
|
Активен |
536 |
| C03CA04 |
Torasemide 100% |
C03CA04 Torasemide 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C03CA04 |
Torasemide |
TORAZIDEX |
Tablet |
5 |
mg |
30 |
Sandoz d.d., Словения |
15 |
mg |
5.68 |
- |
0.426 |
4.26 |
100% |
4.26 |
|
I10 |
HCP-8735/13.04.2016; НСР-13345/28.07.2017 |
02.08.2019 |
08.09.2012 |
|
Активен |
2728 |
| C03CA04 |
Torasemide |
Torsit SR |
Prolonged release tablet |
5 |
mg |
30 |
Ferrer International S.A.,, Испания |
15 |
mg |
4.26 |
- |
0.426 |
4.26 |
100% |
4.26 |
|
I10 |
HCP-10138/31.08.2016; НСР-19357/26.07.2019 |
02.09.2019 |
|
|
Активен |
3317 |
| C03CA04 |
Torasemide |
TRIFAS COR |
Tablet |
5 |
mg |
30 |
Menarini International Operations Luxembourg S.A., Люксембург |
15 |
mg |
7.36 |
- |
0.426 |
4.26 |
100% |
4.26 |
|
I10 |
НСР-19789/10.09.2019 |
02.10.2019 |
08.09.2012 |
|
Активен |
536 |
| C03DA01 |
Spironolactone |
C03DA01 Spironolactone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C03DA01 |
Spironolactone |
SPIRONOLACTON ACTAVIS |
Coated tablet |
25 |
mg |
30 |
Актавис EАД, България |
75 |
mg |
- |
5.08 |
0.35975 |
3.6 |
25% |
0.9 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
|
02.11.2019 |
08.09.2012 |
|
Активен |
235 |
| C03DA01 |
Spironolactone |
Spironolactone Accord |
Film coated tablet |
25 |
mg |
30 |
Accord Healthcare Polska Sp. z.o.o., Полша |
75 |
mg |
- |
5.34 |
0.35975 |
3.6 |
25% |
0.9 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
НСР-16552/24.08.2018; НСР-20110/08.11.2019 |
02.12.2019 |
|
|
Активен |
16236 |
| C03DA01 |
Spironolactone |
Spironolactone Accord |
Film coated tablet |
50 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
75 |
mg |
- |
12.01 |
0.35975 |
7.2 |
25% |
1.8 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
НСР-16552/24.08.2018 |
02.11.2019 |
|
|
Активен |
16237 |
| C03DA01 |
Spironolactone |
SPIRONOLACTON-TCHAIKAPHARMA |
Film coated tablet |
50 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
75 |
mg |
- |
9.82 |
0.35975 |
7.2 |
25% |
1.8 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
НСР-5070/21.11.2014; НСР-18142/07.03.2019; НСР-21674/11.06.2020 |
02.07.2020 |
08.09.2012 |
|
Активен |
3369 |
| C03DA01 |
Spironolactone |
SPIRONOLACTON-TCHAIKAPHARMA |
Film coated tablet |
100 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
75 |
mg |
- |
14.39 |
0.35975 |
14.39 |
25% |
3.59 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
НСР-5071/21.11.2014; НСР-18143/07.03.2019 |
02.11.2019 |
08.09.2012 |
|
Активен |
3370 |
| C03DA01 |
Spironolactone |
SPIRONOLACTON-TCHAIKAPHARMA |
Film coated tablet |
25 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
75 |
mg |
- |
5.76 |
0.35975 |
3.6 |
25% |
0.9 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I50.0,I50.1,K74.0,K74.3,K74.4,K74.5,K74.6,N18.0,N18.8 |
НСР-5069/21.11.2014; НСР-18141/07.03.2019 |
02.11.2019 |
08.09.2012 |
|
Активен |
3368 |